Avacta Share Discussion Threads

[divmad] 24/5/2024 17:48

Why is he still here? Because he has nothing else to look forward to each day in his boring, lonely existence. A sad indictment of a few depressing types across this public bb.

[king suarez] 24/5/2024 17:07

"A woman's work is never done"...

[stmcn] 24/5/2024 15:46

Pwhite - on many occasions, you have stated your work is done and will not post further on this thread - each time, the folks here breathe a sigh of relief and bid you goodbye - only to be disappointed by your repeated returns (usually after no more than a day or two).

Since you are:

1) not an investor in this stock,
2) have little to offer by way of useful or even accurate content, and
3) Loathed by all other participants...

Why are you still here buddy?

[jaknife] 24/5/2024 15:41

PWhite73,

JakNife - "Meanwhile Whitey took outrageous remuneration rewards for failure"

I do not and have never worked for this company.

Apologies, I've obviously got you on my mind. I've corrected it to "Smith".

JakNife

[jaknife] 24/5/2024 15:40

Amanitaangelicus,

"Sorry guys but Avacta must be harnessing newer tech, somewhere in the chain."

Why *must* they? They're relying on dox, which is decades old, that doesn't sound like it's "newer tech" does it?

All of the major pharmas have taken the path of designing targeted cancer drugs that target antibodies rather than a protein (like AVA 6000). Which is the "newer" method?

Or is that even important given that all of the major pharmas have already got their own targeted cancer therapies and most of them have already got FDA approval?

Whilst AstraZeneca are busy spending £1.2bn to build a factory in Singapore that will supply its (FDA approved) targeted cancer therapy to the world, Avacta still haven't finished their Phase 1 trials, despite the fact that AVA 6000 had already completed Phase 1 trials under its original owners, Arisaph!

JakNife

[fuzzy777] 24/5/2024 15:18

Go away you tool

[pwhite73] 24/5/2024 15:14

JakNife - "Meanwhile Whitey took outrageous remuneration rewards for failure"I do not and have never worked for this company.

[1347] 24/5/2024 11:41

Avacta entered into the collaboration with Tufts on 24th July 2018 according to the RNS on that date. 6 years later they are still at Phase 1a. Arisaph had already been working on ARI-3996 and ARI-6000 since 2010, they ended the project in 2016.

[amanitaangelicus] 23/5/2024 18:09

I like big cohorts ...rns better than the silence. Where s Smith? Wish we knew the full story. The ii.s will know of course.

[john henry] 23/5/2024 14:38

That's another one of the hundreds of defamatory remarks you've made about the company. Let's ping the scam one over to Avacta

[john henry] 23/5/2024 14:35

Funds seeing an in flow of money for the first time in 3 years let's see what happens when risk comes back into the market

[pwhite73] 23/5/2024 13:49

For the record all the money PIs invested in this scam are in the hands of Avacta.

[john henry] 23/5/2024 13:12

For the record all your defamatory posts are in the hands of Avacta

[john henry] 23/5/2024 13:10

TBH Whitey I'm surprised you've never had a call from Lawyers. The number of times you've have publicly calked the BOD liars for all to see would imho warrant a court appearance.

[john henry] 23/5/2024 13:07

Kindly comment on one of the trial subjects where if these patients have only months to live as you claim which to be honest you know SFA about there condition.They are still receiving treatment after18 months TBH very disappointing reply and a clutching of straws comment.

[pwhite73] 23/5/2024 12:50

Cancers thrive in healthy bodies and if untreated they eventually kill the healthy host body. Once the host body is dead the cancer cells die as well for there is no live tissue to feed on and expand within.

The patients Avacta are using are terminally ill and not people that have ten years of life left but people with only months if less. So as their bodies weaken the cancers themselves can naturally shrink as they have less healthy tissue to expand within.

This is what an independent review can determine. Has the cancer shrunk in people that are dying because of a weakened body or because of the application of AVA6000.

This whole clinical trial if you can call it that is not kept totally in house for no reason.

[john henry] 23/5/2024 12:39

So how become a patient that been on the Ava6000 trial for 12 months and still on the trial has seen a dramatic shrinkage in his Tumours . Surely if no DOX was being delivered into the Tumour as you claim and that the company are blatantly lying about the data. The scans would have shown a growth in the tumours because as you claim no DOX is being delivered.

[pwhite73] 23/5/2024 12:33

john henry - "So the fact that they have seen no side effects and no Dox in the plasma when dosing 3.5 times the legal limit of Dox suggests to you that Precision doesn’t work."

Yes. They could be dosing 300 times the legal limit and there would be no side effects if the DOX was not been released at all. They've claimed they've recorded DOX in the tumours. This is a totally meaningless statement. How much and when did they record it. Was it the night before the terminally ill patient died?

Their unverified results are totally meaningless.

If they were able to deliver 3.5 times DOX to the tumour with no side effects. Eli Lilly, Pfizer, AstraZeneca et al would be bulldozing Avacta's door down to partner with them. Instead the CEO has resigned or been sacked with no reasons given.